Sofinnova sets out to conquer digital medicine.
The European leader in venture capital specializing in the life sciences is creating a fund dedicated to this field at the crossroads of biology, data and IT, in order to support European start-ups, from the priming at the most advanced stages of their development.
This offensive owes nothing to chance.
Digital medicine is one of the most promising sectors in the life sciences.
It should weigh 100 billion dollars by 2026, with a growth rate of more than 40% per year, according to expert estimates.
This market covers all solutions that use IT and AI to meet the challenges posed by our health systems.
This first integrates the upstream, that is to say the tools that optimize the search, making it faster and more efficient.
The challenge also consists in better targeting treatments with so-called precision medicine which consists in ensuring, from…
This article is for subscribers only.
You have 76% left to discover.
Want to read more?
Unlock all items immediately.
Without engagement.
TEST FOR €0.99
Already subscribed?
Login